Atlas Venture Life Science Advisors
Latest statistics and disclosures from Atlas Venture Life Science Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are DYN, KYMR, IRON, DAWN, THRD, and represent 73.41% of Atlas Venture Life Science Advisors's stock portfolio.
- Added to shares of these 1 stock: Q32 Bio (+$36M).
- Started 1 new stock position in Q32 Bio.
- Reduced shares in these 8 stocks: DYN (-$53M), DAWN (-$20M), KYMR (-$19M), IRON (-$17M), AKRO (-$8.4M), XLO, DNTH, SPRO.
- Sold out of its position in AKRO.
- Atlas Venture Life Science Advisors was a net seller of stock by $-85M.
- Atlas Venture Life Science Advisors has $1.1B in assets under management (AUM), dropping by 29.03%.
- Central Index Key (CIK): 0001917529
Tip: Access up to 7 years of quarterly data
Positions held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 16 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Past Filings by Atlas Venture Life Science Advisors
SEC 13F filings are viewable for Atlas Venture Life Science Advisors going back to 2022
- Atlas Venture Life Science Advisors 2024 Q1 filed May 6, 2024
- Atlas Venture Life Science Advisors 2023 Q4 filed Feb. 9, 2024
- Atlas Venture Life Science Advisors 2023 Q3 filed Nov. 13, 2023
- Atlas Venture Life Science Advisors 2023 Q2 filed Aug. 11, 2023
- Atlas Venture Life Science Advisors 2023 Q1 filed May 15, 2023
- Atlas Venture Life Science Advisors 2022 Q4 filed Feb. 14, 2023
- Atlas Venture Life Science Advisors 2022 Q3 filed Nov. 9, 2022
- Atlas Venture Life Science Advisors 2022 Q2 filed Aug. 3, 2022
- Atlas Venture Life Science Advisors 2021 Q4 filed May 16, 2022
- Atlas Venture Life Science Advisors 2022 Q1 filed May 16, 2022